Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-((1E,3E,5E,7E)-7-(3-((S)-1-((4R,10S,13S,16S,19S,22S,28R)-22-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-4-carboxy-13-(3-guanidinopropyl)-16,19-diisopropyl-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octaazacyclononacosan-28-ylamino)-23-(18-((4R,10S,13S,16S,19S,22S,28R)-22-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-4-carboxy-13-(3-guanidinopropyl)-16,19-diisopropyl-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octaazacyclononacosan-28-ylamino)-15,18-dioxo-3,6,9,12-tetraoxa-16-azaoctadecylcarbamoyl)-1,4,20,25-tetraoxo-7,10,13,16-tetraoxa-3,19,24-triazatriacontan-30-yl)-1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)hepta-1,3,5-trienyl)-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium
ID: ALA5177925
Chembl Id: CHEMBL5177925
PubChem CID: 168274624
Max Phase: Preclinical
Molecular Formula: C146H221N35O42S5
Molecular Weight: 3298.91
Associated Items: